EBOS Group Limited
Research EBOS Group Limited (EJG) on Bullrun: market cap EUR 2.06B, P/E 15.6, dividend yield 6.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEJG
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyEUR
- Market capEUR 2.06B
- P/E15.6
- Dividend yield6.1%
- Financial periodFY2025
- RevenueEUR 13.21B
- Revenue growth-8.3%
- Net incomeEUR 231.66M
- Free cash flowEUR 396.38M
- Gross margin13.3%
Valuation Snapshot
latest market cap is EUR 2.06B; P/E is 15.6; dividend yield is 6.1%.
About EBOS Group Limited
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
Frequently asked questions
What is EBOS Group Limited's market cap?
EBOS Group Limited's market capitalization is EUR 2.06B.
What is EBOS Group Limited's P/E ratio?
EBOS Group Limited's price-to-earnings (P/E) ratio is 15.6.
Does EBOS Group Limited pay a dividend?
EBOS Group Limited has a dividend yield of 6.1%.
What does EBOS Group Limited do?
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics;